Literature DB >> 8426091

Selective refractoriness of macrophages to endotoxin-induced production of tumor necrosis factor, elicited by an autocrine mechanism.

H Fahmi1, R Chaby.   

Abstract

Tolerance of macrophages to endotoxin (lipopolysaccharide, LPS) can be induced in vitro by LPS itself. We show here that one of the mechanisms of tolerance to LPS can be mediated via an autocrine process. Continuous exposure to LPS is not required to induce macrophage desensitization. Refractoriness to production of tumor necrosis factor (TNF) in response to LPS can be transferred from tolerant to naive macrophage populations by incubation of the latter with the culture supernatant of the former, in the absence of endotoxin. The active factor present in this macrophage-desensitizing culture supernatant (MD-Sup) is more efficiently removed by incubation with tolerant macrophages than by incubation with naive macrophages. The refractoriness elicited by treatment with MD-Sup is restricted to a decreased TNF response to LPS; interleukin-1 (IL-1) and IL-6 responses are not affected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426091     DOI: 10.1002/jlb.53.1.45

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  Functional lipopolysaccharide receptors of low affinity are constitutively expressed on mouse bone marrow cells.

Authors:  R Girard; T Pedron; R Chaby
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 2.  [T cell-dependent monocyte activation, TNFalpha and apolipoprotein A-I in autoimmunity and inflammation].

Authors:  M Rossol; H Häntzschel; U Wagner
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

3.  Involvement of the membrane form of tumour necrosis factor-alpha in lipopolysaccharide-induced priming of mouse peritoneal macrophages for enhanced nitric oxide response to lipopolysaccharide.

Authors:  P Ancuta; H Fahmi; J F Pons; K Le Blay; R Chaby
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

4.  Improved innate immunity of endotoxin-tolerant mice increases resistance to Salmonella enterica serovar typhimurium infection despite attenuated cytokine response.

Authors:  M D Lehner; J Ittner; D S Bundschuh; N van Rooijen; A Wendel; T Hartung
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  A simple mathematical model of signaling resulting from the binding of lipopolysaccharide with Toll-like receptor 4 demonstrates inherent preconditioning behavior.

Authors:  Beatrice Rivière; Yekaterina Epshteyn; David Swigon; Yoram Vodovotz
Journal:  Math Biosci       Date:  2008-10-11       Impact factor: 2.144

6.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

Authors:  D J Berg; R Kühn; K Rajewsky; W Müller; S Menon; N Davidson; G Grünig; D Rennick
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Distinct tumor necrosis factor-alpha responses in alveolar and peritoneal macrophages are associated with local levels of endotoxin.

Authors:  L F Wang; K Tomita; T Sasaki
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

8.  Preexposure of mouse peritoneal macrophages to lipopolysaccharide and other stimuli enhances the nitric oxide response to secondary stimuli.

Authors:  H Fahmi; P Ancuta; S Perrier; R Chaby
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

9.  Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production.

Authors:  H Fahmi; D Charon; M Mondange; R Chaby
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50.

Authors:  M Baer; A Dillner; R C Schwartz; C Sedon; S Nedospasov; P F Johnson
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.